Daybreak Special: The Pharmeasy Investigation

<p>In this week's Daybreak Special episode, hosts Snigdha Sharma and Rahel Philipose speak to The Ken's Shivani Verma about her investigation into Pharmeasy's dubious business practices. </p><p>The once IPO-bound company is under the scanner for its 'unethical' ways of upselling alternative medicines and supplements. Everyone – from Pharmeasy's own pharmacists, to the doctors who call behalf of the company to validate a customer's prescription – are under pressure to sell these supplements. </p><p>The saga began with Pharmeasy’s 2021  acquisition of Bengaluru-based e-pharmacy Medlife, where former executives noted a similar trend of upselling alternatives and supplements.  This comes amid ballooning losses and immense pressure from investors to show profitability. </p><p>So what's the deal? Why is Pharmeasy going down this route? </p><p>Tune in to find out. </p><p><em>Daybreak is produced from the newsroom of The Ken, India’s first subscriber-only business news platform. Subscribe for more exclusive, deeply-reported, and analytical business stories.</em></p><p>P.S. Daybreak episodes drop daily now :)</p>